ozempic pause
Prescription Weight Loss Breaks Pose Hidden Rebound Danger?
Stopping a GLP-1 like semaglutide or tirzepatide often triggers rapid weight regain and can stir new health concerns. The FDA’s recent proposal to remove these drugs from the 503B bulk-compounding list adds a regulatory layer that may limit patients’ ability to obtain off-label doses during a break. In 2024,